title: Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons.
abstract: During 1979-1995, there was no vaccination against pertussis in Sweden. With the aim of studying the epidemiology and transmission of pertussis, mass vaccination with pertussis toxoid of children born during the 1990s was instituted in the Göteborg area (population, 778,597) in 1995. Infants were offered 3 doses of pertussis toxoid combined with diphtheria and tetanus toxoids. Children aged > or =1 year were offered 3 doses of pertussis toxoid alone. From June 1995 through February 1999, 167,810 doses of pertussis toxoid were given to 61,219 children born during the 1990s (56% received 3 doses). The number of Bordetella pertussis isolates per year declined from 1214 (1993-1995) to 64 (January 1997 through June 1999; P<.0001), and hospitalizations due to pertussis declined from 62 to 5 (P<.0001). Significant decreases in B. pertussis isolates and hospitalizations occurred in all age groups, including adults and nonvaccinated infants. Thus, mass vaccination of children with pertussis toxoid decreases spread of B. pertussis in the population.
authors.affiliation: Göteborg Pertussis Vaccine Study, Göteborg Primary Health Care, Department of Medical Microbiology, Göteborg University, Göteborg, Sweden.
authors.forename: J
authors.initials: J
authors.lastname: Taranger
authors.forename: B
authors.initials: B
authors.lastname: Trollfors
authors.forename: E
authors.initials: E
authors.lastname: Bergfors
authors.forename: N
authors.initials: N
authors.lastname: Knutsson
authors.forename: V
authors.initials: V
authors.lastname: Sundh
authors.forename: T
authors.initials: T
authors.lastname: Lagergård
authors.forename: L
authors.initials: L
authors.lastname: Lind-Brandberg
authors.forename: G
authors.initials: G
authors.lastname: Zackrisson
authors.forename: J
authors.initials: J
authors.lastname: White
authors.forename: H
authors.initials: H
authors.lastname: Cicirello
authors.forename: J
authors.initials: J
authors.lastname: Fusco
authors.forename: J B
authors.initials: JB
authors.lastname: Robbins
mesh_terms: D000293:Adolescent; D000907:Antibodies, Bacterial / Q000097:blood; D001886:Bordetella pertussis / Q000276:immunology* / Q000302:isolation & purification; D002648:Child; D002675:Child, Preschool; D015721:Diphtheria-Tetanus-Pertussis Vaccine / Q000008:administration & dosage*; D006801:Humans; D015994:Incidence; D007223:Infant; D010567:Pertussis Vaccine / Q000008:administration & dosage* / Q000276:immunology; D013548:Sweden / Q000453:epidemiology; D014121:Toxoids / Q000008:administration & dosage* / Q000276:immunology; D014611:Vaccination; D014917:Whooping Cough / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission
chemical_list: D000907:Antibodies, Bacterial; D015721:Diphtheria-Tetanus-Pertussis Vaccine; D010567:Pertussis Vaccine; D014121:Toxoids; C051093:pertussis toxoid